The global aquaculture vaccines market size was USD 3.76 Billion in 2022 and is expected to register a revenue CAGR of 8.40% over the forecast period, according to the latest report by Reports and Data.
The demand for fish and seafood is expanding due to population increase and changing dietary tastes, and there is a growing need for vaccinations to protect aquatic animals from various diseases and illnesses. These are the main drivers influencing market revenue growth. Other factors influencing market revenue growth include the rise in government initiatives to support aquaculture, technological developments for the production of more effective and efficient vaccines for aquatic animals, and the demand for vaccines and other preventative treatments to protect aquatic animals from illnesses and infections.
Get a sample copy of the Domain Name system (DNS) Service Market report, visit @ https://www.reportsanddata.com/download-free-sample/5960
Some Key Highlights from the Report
- The primary reason for the expected dominant revenue share of the attenuated live vaccines segment is the growing need for vaccines to protect vital aquaculture species such as tilapia and salmon against various viral and bacterial infections. Attenuated live vaccines function by reducing the virulence of the pathogen, allowing it to stimulate an immune response in animals without causing illness.
- The fastest growth in revenue is expected to be seen in the viral segment, attributed to the rising adoption of viral vaccines that provide effective and durable protection against a variety of virus strains.
- During the forecast period, the Asia Pacific market is anticipated to contribute the greatest revenue share. This is a result of the region's aquaculture species having a high frequency of contagious diseases, the expanding demand for seafood, and the need for eco-friendly and sustainable aquaculture techniques.
- Some major companies profiled in the global market report are Hipra, Zoetis, Merck Animal Health, Elanco, Indian Immunologicals, Fish Vet Group, Vaccibody AS, Novartis AG, Tecnovax, Pfizer, Intervet Inc., BioMarin Pharmaceutical Inc., AquaBounty Technologies, Ridgeway Biologicals Ltd., and Vaxxinova.
To know more about the latest insights of the report, visit @ https://www.reportsanddata.com/request-latest-insight/5960
For the purpose of this report, Reports and Data has segmented the global aquatic vaccines market on the basis of Product Outlook, Route of Administration Outlook, Application Outlook, and Regional Outlook:
Product Outlook (Revenue, USD Billion; 2019-2032)
- Attenuated Live Vaccines
- Inactivated Vaccines
- Subunit vaccines
- DNA Vaccines
- Recombinant Vaccines
Route of Administration Outlook (Revenue, USD Billion; 2019-2032)
- Oral
- Injected
- Immersion and spray
Application Outlook (Revenue, USD Billion; 2019-2032)
- Bacterial
- Viral
- Parasitic
Regional Outlook (Revenue, USD Billion; 2019-2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Request a customized copy of the report @
https://www.reportsanddata.com/request-customization-form/5960
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
